These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary Mycobacterium fortuitum infection in an HIV-infected patient. Ersoz G; Kaya A; Cayan S; Kandemir O; Ergin A; Cetinkaya Y; Unal S AIDS; 2000 Dec; 14(17):2802-3. PubMed ID: 11125907 [No Abstract] [Full Text] [Related]
3. [Lung diseases due to atypical mycobacteria]. Favez G Schweiz Med Wochenschr; 1975 Aug; 105(31):987-91. PubMed ID: 1153999 [TBL] [Abstract][Full Text] [Related]
4. Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum. Ichiyama S; Tsukamura M Chest; 1987 Dec; 92(6):1110-2. PubMed ID: 3479304 [TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. Kunin M; Salamon F; Weinberger M; Genkin I; Sagie A; Tur-Kaspa R Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):539-41. PubMed ID: 12172746 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterium fortuitum infection in a patient with chronic lymphocytic leukaemia. Robinson H; Smith S Br J Haematol; 2004 Oct; 127(2):126. PubMed ID: 15461617 [No Abstract] [Full Text] [Related]
7. [Pulmonary mycobacteriosis due to Mycobacterium battey with favorable development under medical treatment]. Constans P; Parrot R; Aubriot G; Morin Y; Bariéty M Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):957-66. PubMed ID: 5402998 [No Abstract] [Full Text] [Related]
8. Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH). Morimoto K; Kazumi Y; Maeda S; Yoshimori K; Yoshiyama T; Ogata H; Kurashima A; Kudoh S Intern Med; 2011; 50(11):1251-3. PubMed ID: 21628944 [TBL] [Abstract][Full Text] [Related]
9. Death due to Mycobacterium fortuitum. CORPE RF; SMITH CE; STERGUS I JAMA; 1961 Jul; 177():262-3. PubMed ID: 13695634 [No Abstract] [Full Text] [Related]
10. Refractory asthma coexisting with a double aortic arch: a case report and literature review. Yang HJ; Pyun BY J Asthma; 2010 Dec; 47(10):1165-7. PubMed ID: 20946085 [TBL] [Abstract][Full Text] [Related]
11. [Solid combination of budesonide and formoterol in the treatment of bronchial asthma]. Gillissen A; Buhl R; Magnussen H; Menz G; Rabe K; Vogelmeier C; Worth H Pneumologie; 2001 Mar; 55(3):159-62. PubMed ID: 11293852 [No Abstract] [Full Text] [Related]
13. Effect of inhaled formoterol and budesonide on exacerbations of asthma. FitzGerald JM N Engl J Med; 1998 Apr; 338(15):1071-2; author reply 1072. PubMed ID: 9537879 [No Abstract] [Full Text] [Related]
14. Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma--another view. Ketcher LD; Bettenhausen DK; Shah T Pharmacotherapy; 1999 Oct; 19(10):1189-90. PubMed ID: 10512073 [No Abstract] [Full Text] [Related]
19. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results]. Krebs A Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190 [No Abstract] [Full Text] [Related]
20. [Lipid pneumonia and superinfection by Mycobacterium fortuitum. Apropos of a case]. Vincent M; Chambon M; Fougerat J; Loire R; Economides A Rev Mal Respir; 1987; 4(6):335-8. PubMed ID: 3441680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]